Deletion of Mineralocorticoid Receptors From Macrophages Protects Against Deoxycorticosterone/Salt-Induced Cardiac Fibrosis and Increased Blood Pressure

被引:253
作者
Rickard, Amanda J. [1 ,3 ]
Morgan, James [1 ]
Tesch, Greg [2 ]
Funder, John W. [1 ]
Fuller, Peter J. [1 ]
Young, Morag J. [1 ,3 ]
机构
[1] Monash Univ, Prince Henrys Inst Med Res, Clayton, Vic 3168, Australia
[2] Monash Univ, Dept Nephrol, Monash Med Ctr, Clayton, Vic 3168, Australia
[3] Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia
基金
英国医学研究理事会;
关键词
macrophages; monocytes; mineralocorticoid receptor; cardiac fibrosis; inflammation; tissue remodeling; ANGIOTENSIN-II; INFLAMMATORY RESPONSES; HEART-FAILURE; GLUCOCORTICOID-RECEPTOR; MONONUCLEAR LEUKOCYTES; MYOCARDIAL FIBROSIS; OXIDATIVE STRESS; KNOCKOUT MICE; NADPH OXIDASE; ACETATE-SALT;
D O I
10.1161/HYPERTENSIONAHA.109.131110
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Increased mineralocorticoid levels plus high salt promote vascular inflammation and cardiac tissue remodeling. Mineralocorticoid receptors are expressed in many cell types of the cardiovascular system, including monocytes/macrophages and other inflammatory cell types. Although mineralocorticoid receptors are expressed in monocytes/macrophages, their role in regulating macrophage function to date has not been investigated. We, thus, used the Cre/LoxP-recombination system to selectively delete mineralocorticoid receptors from monocytes/macrophages with the lysozyme M promoter used to drive Cre expression (MRflox/flox/LysM(Cre/-) mice). Male mice from each genotype (MRflox/flox or wild-type and MRflox/flox/LysM(Cre/-) mice) were uninephrectomized, given 0.9% NaCl solution to drink, and treated for 8 days or 8 weeks with either vehicle (n = 10) or deoxycorticosterone (n = 10). Equivalent tissue macrophage numbers were seen for deoxycorticosterone treatment of each genotype at 8 days; in contrast, plasminogen activator inhibitor type 1 and NAD(P) H oxidase subunit 2 levels were increased in wild-type but not in MRflox/flox/ LysM(Cre/-) mice given deoxycorticosterone. Baseline expression of other inflammatory genes was reduced in MRflox/flox/LysM(Cre/-) mice compared with wild-type mice. At 8 weeks, deoxycorticosterone-induced macrophage recruitment and connective tissue growth factor and plasminogen activator inhibitor type 1 mRNA levels were similar for each genotype; in contrast, MRflox/flox/LysM(Cre/-) mice showed no increase in cardiac fibrosis or blood pressure, as was seen in wild-type mice at 8 weeks. These data demonstrate the following points: (1) mineralocorticoid receptor signaling regulates basal monocyte/macrophage function; (2) macrophage recruitment is not altered by loss of mineralocorticoid receptor signaling in these cells; and (3) a novel and significant role is seen for macrophage signaling in the regulation of cardiac remodeling and systolic blood pressure in the deoxycorticosterone/salt model. (Hypertension. 2009; 54: 537-543.)
引用
收藏
页码:537 / U180
页数:19
相关论文
共 49 条
[1]   Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction [J].
Amiri, F ;
Virdis, A ;
Neves, MF ;
Iglarz, M ;
Seidah, NG ;
Touyz, RM ;
Reudelhuber, TL ;
Schiffrin, EL .
CIRCULATION, 2004, 110 (15) :2233-2240
[2]  
ARMANINI D, 1985, J HYPERTENS, V3, pS157
[3]   Blunted DOCA/high salt induced albuminuria and renal tubulointerstitial damage in gene-targeted mice lacking SGK1 [J].
Artune, Ferruh ;
Amann, Kerstin ;
Nasir, Omaima ;
Friedrich, Bjorn ;
Sandulache, Diana ;
Jahovic, Nermina ;
Risler, Teut ;
Vallon, Volker ;
Wulff, Peer ;
Kuhl, Dietmar ;
Lang, Florian .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2006, 84 (09) :737-746
[4]   Loss of the limbic mineralocorticoid receptor impairs behavioral plasticity [J].
Berger, S ;
Wolfer, DP ;
Selbach, O ;
Alter, H ;
Erdmann, G ;
Reichardt, HM ;
Chepkova, AN ;
Welzl, H ;
Haas, HL ;
Lipp, HP ;
Schütz, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (01) :195-200
[5]   Mineralocorticoid receptor knockout mice:: Pathophysiology of Na+ metabolism [J].
Berger, S ;
Bleich, M ;
Schmid, W ;
Cole, TJ ;
Peters, J ;
Watanabe, H ;
Kriz, W ;
Warth, R ;
Greger, R ;
Schütz, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (16) :9424-9429
[6]  
BRILLA CG, 1992, J LAB CLIN MED, V120, P893
[7]   REACTIVE AND REPARATIVE MYOCARDIAL FIBROSIS IN ARTERIAL-HYPERTENSION IN THE RAT [J].
BRILLA, CG ;
WEBER, KT .
CARDIOVASCULAR RESEARCH, 1992, 26 (07) :671-677
[8]  
BRILLA CG, 1995, EUR HEART J, V16, pC45
[9]   Aldosterone and end-organ damage [J].
Brown, NJ .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2005, 14 (03) :235-241
[10]   Effect of aldosterone and glycyrrhetinic acid on the protein expression of PAI-1 and p22phox in human mononuclear leukocytes [J].
Calò, LA ;
Zaghetto, F ;
Pagnin, E ;
Davis, PA ;
de Mozzi, P ;
Sartorato, P ;
Martire, G ;
Fiore, C ;
Armanini, D .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (04) :1973-1976